North America Fluorescent Immunoassay Market Forecast to 2028

Report Code : BMIRE00025665 | Region : North America | Industry : Biotechnology | Published Date : 10/Aug/2022
North America Fluorescent Immunoassay Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (ELISA, Rapid Lateral Flow Immunoassay, and Others), Application (Infectious Diseases, Oncology, Cardiovascular Diseases, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others)

The North America fluorescent immunoassay market is expected to grow from US$ 1,072.41 million in 2021 to US$ 1,598.58 million by 2028; it is estimated to register a CAGR of 5.9% from 2021 to 2028.

Fluorescent immunoassays are diagnostic tools for quality control and the quantity-specific detection of antigens and antibodies. The technique derives from the fundamental immunological concept of antigen-antibody binding. These are used in screening to quantify the production or inhibition of antigens/haptens associated with a disease target. These antigens or haptens are characteristic of the disease process and are mediated by the target, such as cytokines or growth factors. Cell therapy is the practice of using cellular material to produce the desired effect in vitro or in vivo through their biological activities and properties. The cells used for the treatments can be classified as either allogeneic or autologous. Modern cell-based therapies also include regenerating human cells, tissue, or organs. The basis of the cells used comes from the stem and progenitor cells, mature and functionally differentiated cells, or artificially produced tissue. Fluorescence-activated cell sorting (FACS) is a highly flexible technique with many options for stem cell sorting. It is also the only way to isolate a particular stem cell population using multiple internal and external markers. FACS is a specialized type of flow cytometry that sorts a heterogeneous mixture of cells based on each cell's specific light scatter and fluorescence properties. Cells are first tagged with fluorescent antibodies that bind to relevant proteins on target cells. Single cells pass a laser beam, and a detector measures fluorescence, forward scattered light (FSC), and side spread light (SSC). FSC and SSC are used to determine the size of the cell. Fluorescence at multiple wavelengths can be detected simultaneously but depends on the instrument's specific lasers, filters, and detectors. The cells are then physically sorted into different bins based on captured measurements and user-entered parameters. Fluorescence-activated cell sorting allows for current and future need for cell isolation to conduct efficient stem cell research. Thus, there is a growing demand for fluorescent immunoassays for providing quality and quantity-specific detection of antigens and antibodies.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America fluorescent immunoassay market at a notable CAGR during the forecast period.

North America Fluorescent Immunoassay Market Revenue and Forecast to 2028 (US$ Million)

North America Fluorescent Immunoassay Market Segmentation

The North America fluorescent immunoassay market is segmented into product type, application, end user, and country. Based on product type, the market is segmented into ELISA, rapid lateral flow immunoassay, and others. The ELISA segment dominated the market in 2021 and is expected to register the highest CAGR during the forecast period. Based on application, the market is segmented into infectious diseases, oncology, cardiovascular diseases, and others. The infectious disease segment dominated the market in 2021 and is expected to register the highest CAGR during the forecast period. Based on end user, the market is segmented into hospitals & clinics, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others. The hospitals and clinics segment dominated the market in 2021 and is expected to register the highest CAGR during the forecast period. Based on country, the North America fluorescent immunoassay market is segmented into the US, Canada, and Mexico.

Abbott, BD, bioMerieux SA, Danaher, F. Hoffmann-La Roche Ltd., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific Inc. are among the leading companies operating in the North America fluorescent immunoassay market.

The List of Companies - North America Fluorescent Immunoassay Market

● Abbott

● BD

● bioMerieux SA

● Danaher

● F. Hoffmann-La Roche Ltd.

● Ortho Clinical Diagnostics Holdings plc

● Quidel Corporation

● Siemens AG

● Sysmex Corporation

● Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Fluorescent Immunoassay Market – By Product Type

1.3.2 North America Fluorescent Immunoassay Market – By Application

1.3.3 North America Fluorescent Immunoassay Market – By End User

1.3.4 North America Fluorescent Immunoassay Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Fluorescent Immunoassay Market – Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Expert Opinions

5. North America Fluorescent Immunoassay Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Prevalence of Chronic Diseases

5.1.2 Increasing Demand for Cell Therapies

5.2 Market Restraints

5.2.1 Disadvantages of Fluorescent Immunoassays

5.3 Market Opportunities

5.3.1 Extensive Usage in Cancer Diagnostics

5.4 Future Trends

5.4.1 Increase in Development of Fluorescent Dyes and Instruments

5.5 Impact Analysis

6. Fluorescent Immunoassay Market – North America Analysis

6.1 North America Fluorescent Immunoassay Marker Revenue Forecast and Analysis

7. North America Fluorescent Immunoassay Market Analysis – By Product Type

7.1 Overview

7.2 North America Fluorescent Immunoassay Market Share by Product Type - 2021 & 2028 (%)

7.3 ELISA

7.3.1 Overview

7.3.2 ELISA: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

7.4 Rapid Lateral Flow Immunoassay

7.4.1 Overview

7.4.2 Rapid Lateral Flow Immunoassay: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8. North America Fluorescent Immunoassay Market Analysis – By Application

8.1 Overview

8.2 North America Fluorescent Immunoassay Market Share by Application - 2021 & 2028 (%)

8.3 Infectious Diseases

8.3.1 Overview

8.3.2 Infectious Diseases: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8.4 Oncology

8.4.1 Overview

8.4.2 Oncology: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8.5 Cardiovascular Disease

8.5.1 Overview

8.5.2 Cardiovascular Disease: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9. North America Fluorescent Immunoassay Market Analysis – By End User

9.1 Overview

9.2 North America Fluorescent Immunoassay Market Share by End User - 2021 & 2028 (%)

9.3 Hospitals & Clinics

9.3.1 Overview

9.3.2 Hospitals & Clinics: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.4 Diagnostic Centers

9.4.1 Overview

9.4.2 Diagnostic Centers: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.5 Pharmaceutical & Biotechnology Companies

9.5.1 Overview

9.5.2 Pharmaceutical & Biotechnology Companies: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.6 Academic & Research Institutes

9.6.1 Overview

9.6.2 Academic & Research Institutes: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

10. North America Fluorescent Immunoassay Market Analysis – By Country

10.1 Overview

10.1.1 North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1 US: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)

10.1.1.1.1 Overview

10.1.1.1.2 US: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.1.1.1.3 US: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.4 US: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.5 US: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.2 Canada: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)

10.1.1.2.1 Overview

10.1.1.2.2 Canada: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.1.1.2.3 Canada: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.4 Canada: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.5 Canada: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.3 Mexico: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1 Overview

10.1.1.3.2 Mexico: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.1.1.3.3 Mexico: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.4 Mexico: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.5 Mexico: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Thermo Fisher Scientific Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Abbott

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 BD

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Danaher

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 bioMerieux SA

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Sysmex Corporation

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Siemens AG

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Ortho Clinical Diagnostics Holdings plc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Quidel Corporation

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About the Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1.             North America Fluorescent Immunoassay Market –Revenue and Forecast to 2028 (USD Million)

Table 2.             US: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             US: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             US: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.             Canada: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 6.             Canada: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7.             Canada: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 8.             Mexico: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 9.             Mexico: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10.          Mexico: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 11.          Organic Developments

Table 12.          Inorganic Developments

Table 13.          Glossary of Terms

The List of Companies - North America Fluorescent Immunoassay Market

● Abbott

● BD

● bioMerieux SA

● Danaher

● F. Hoffmann-La Roche Ltd.

● Ortho Clinical Diagnostics Holdings plc

● Quidel Corporation

● Siemens AG

● Sysmex Corporation

● Thermo Fisher Scientific Inc.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America fluorescent immunoassay market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the North America fluorescent immunoassay market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the fluorescent immunoassay market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(North America Fluorescent Immunoassay Market Forecast to 2028 )
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry